# Alembic Pharmaceuticals Limited (Units I and II) - Inspection Records

Source: https://www.keypedia.com/companies/alembic-pharmaceuticals-limited-units-i-and-ii/68fd4724-f974-4ddc-8882-a5d28dc90916

> Inspection records and compliance data for Alembic Pharmaceuticals Limited (Units I and II) in Panchmahal, None. Access full analysis and detailed observations.

---

## Details

- Name: Alembic Pharmaceuticals Limited (Units I and II)
- FEI Number: 3003821360
- City: Panchmahal
- State: None
- Country Name: India
- Address Line 1: Api Division, Village Panelav P O Tajpura, Near Baska, Taluka Halol
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - Alembic Pharmaceuticals Limited (Units I and II) - 2025-05-31](https://www.keypedia.com/records/483/alembic-pharmaceuticals-limited-units-i-and-ii/f200c308-1b31-4876-9642-bc0c3f9c2920) — source: FDA, date: May 31, 2025
- [483 - Alembic Pharmaceuticals Limited (Units I and II) - 2025-05-31](https://www.keypedia.com/records/483/alembic-pharmaceuticals-limited-units-i-and-ii/d93249a3-40b4-4a57-b7b3-726eaec789cf) — source: FDA, date: May 31, 2025
- [FDA Inspection 1270216 - Alembic Pharmaceuticals Limited (Units I and II) - 2025-05-31](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/ba9076d1-2082-46d5-bc86-a9f09fe8f8d6) — source: FDA, date: May 31, 2025
- [FDA Inspection 1270216 - Alembic Pharmaceuticals Limited (Units I and II) - 2025-05-31](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/ba2be12f-05d4-4c32-917a-a811650f8ece) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 31, 2025
- [483 - Alembic Pharmaceuticals Limited (Units I and II) - 2025-05-26](https://www.keypedia.com/records/483/alembic-pharmaceuticals-limited-units-i-and-ii/572804fe-e82a-4cba-8325-58bdcf2ed319) — source: FDA, date: May 26, 2025
- [FDA Inspection 1249881 - Alembic Pharmaceuticals Limited (Units I and II) - 2024-10-08](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/435e4d85-9beb-4883-95fd-459421beffc1) — source: FDA, date: October 8, 2024
- [FDA Inspection 1249881 - Alembic Pharmaceuticals Limited (Units I and II) - 2024-10-08](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/56945324-5d2c-4de3-b337-fddb20579310) — classification: No Action Indicated (NAI), source: FDA, date: October 8, 2024
- [FDA Inspection 1055013 - Alembic Pharmaceuticals Limited (Units I and II) - 2018-04-23](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/7513aa52-332c-420f-8825-1c5dd29fe9cc) — classification: No Action Indicated (NAI), source: FDA, date: April 23, 2018
- [FDA Inspection 982077 - Alembic Pharmaceuticals Limited (Units I and II) - 2016-06-29](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/8a0992f9-5d70-4e3c-b462-9dbd73b80d59) — classification: No Action Indicated (NAI), source: FDA, date: June 29, 2016
- [FDA Inspection 831397 - Alembic Pharmaceuticals Limited (Units I and II) - 2013-04-18](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/f5daac28-3db1-4747-a2bb-9d13345640a3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 18, 2013
- [FDA Inspection 831337 - Alembic Pharmaceuticals Limited (Units I and II) - 2013-04-12](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/9d9f1553-27d5-4076-91fc-fbc588186dba) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 12, 2013
- [FDA Inspection 726141 - Alembic Pharmaceuticals Limited (Units I and II) - 2011-04-13](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/48dec3ba-61ee-4231-85d8-59a2dba16864) — classification: No Action Indicated (NAI), source: FDA, date: April 13, 2011
- [FDA Inspection 725644 - Alembic Pharmaceuticals Limited (Units I and II) - 2011-04-06](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/587137ca-5832-4258-96d0-eb250d80a372) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 6, 2011

## Related Companies

- [Alps Pharmaceutical Industrial Co., Ltd.](https://www.keypedia.com/companies/alps-pharmaceutical-industrial-co-ltd/d68f79f1-c4d0-4161-93c1-5f9a0cbd6d05)
- [Veranova LP](https://www.keypedia.com/companies/veranova-lp/22f7ea09-da55-4ee1-aa40-fce66fa3ef61)
- [Hikal Limited](https://www.keypedia.com/companies/hikal-limited/cb3e9445-04eb-4d52-af78-793b43f9d61f)
- [ChemPacific Corporation](https://www.keypedia.com/companies/chempacific-corporation/193b1f68-27d2-4a77-af09-995fc39a7c20)
- [AURORIUM LLC](https://www.keypedia.com/companies/aurorium-llc/1381f644-a64d-49a5-a1bb-b57426080e7d)
- [MicroBiopharm Japan Co., Ltd.](https://www.keypedia.com/companies/microbiopharm-japan-co-ltd/30cd7895-86c9-46ed-bee9-e7131c700977)
- [Jiangsu Baozong & Baoda Pharmachem Co., Ltd.](https://www.keypedia.com/companies/jiangsu-baozong-baoda-pharmachem-co-ltd/b353c82d-34a4-40db-8541-3540be220c7d)
- [Xinyu Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/xinyu-pharmaceutical-co-ltd/f603cb84-26a5-448f-9d9d-c25547afa6b7)
- [Roquette America, Inc.](https://www.keypedia.com/companies/roquette-america-inc/a980f301-3e29-420c-947b-736aa8f6e5f3)
- [Zhejiang Guobang Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/zhejiang-guobang-pharmaceutical-co-ltd/26334d34-b5ce-4ef2-ab1d-455003edad45)

## Related Officers

- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [company_representative](https://www.keypedia.com/people/pradeep-chakravarty/ce40b2f5-9552-4b72-9df3-cde3be0504b2)